Books on the topic 'Antitumour'

1938-, Gielen M., ed. Tin-based antitumour drugs. Berlin: Springer-Verlag, 1990.

Gielen, M., ed. Tin-Based Antitumour Drugs. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74191-3.

V, Wilman Derry E., ed. The chemistry of antitumour agents. London: Blackie, 1990.

Gate, Ernest Nicholas. Investigations on new antitumour agents. Birmingham: University of Aston in Birmingham. Department of Pharmaceutical Sciences, 1985.

Wilman, Derry E. V., ed. The Chemistry of Antitumour Agents. Dordrecht: Springer Netherlands, 1990. http://dx.doi.org/10.1007/978-94-009-0397-5.

Horspool, Keith Ronald. Structure-activity studies on antitumour imidazotetrazionones. Birmingham: Aston University. Departmentof Pharmaceutical Sciences, 1988.

Shahbakhti, Hassan. Structure/activity relationships of antitumour diaziridinylquinones. Salford: University of Salford, 1996.

Blackman, Claire. Studies on carbinolamine-containing triazine antitumour agents. Portsmouth: University of Portsmouth, 1994.

Hickman, John Angus. Studies of the mechanism of action of antitumour compounds. Birmingham: Aston University. Department of Pharmaceutical Sciences, 1989.

Gdarah, Khaled M. The synthesis of some nucleoside analogues as antitumour agents. Uxbridge: Brunel University, 1993.

Clark, Alan Stephen. Antitumour imidazotetrazines: Probes for the major groove of DNA. Birmingham: Aston University. Departmentof Pharmaceutical Sciences, 1991.

Secrett, Peter Clement. Orally active antitumour agents, patient compliance and clinical trials. Birmingham: Aston University Department of Pharmaceutical Sciences, 1988.

Deans, Bryan. Studies on the mechanism of action on antitumour imidazotetrazinones. Birmingham: Aston University. Department ofPharmaceutical and Biological Sciences, 1994.

Bill, Colin Andrew. Studies of the mechanism of antitumour activity of N-methylformamide. Birmingham: Aston University. Department of Pharmaceutical Sciences, 1987.

Hafiz, Farida Bibi. Studies on the interaction of the pyrrolobenzodiazepine antitumour antibiotics with DNA. Portsmouth: University of Portsmouth, School of Pharmacy and Biomedical Sciences, 1998.

Banks, Jason George. Development of C8-linker chemistry for the pyrrolobenzodiazipine [sic.] antitumour antibiotics. Portsmouth: University of Portsmouth, School of Pharmacy and Biomedical Sciences, 1999.

Fisher, Geoffrey Roy. Free radical formation and DNA damage in the cytotoxicity of alkylaminoanthraquinone antitumour agents. Leicester: Leicester Polytechnic, 1989.

Gescher, Andreas. Studies of the metabolism, antitumour activity and toxicity of compounds containing N-Methyl moieties. Birmingham: Aston University. Department of Pharmaceutical Sciences, 1986.

Sagnou, Marina J. Rational design, synthesis and biological evaluation of prodrugs of the pyrrolobenzodiazepine family of antitumour antibiotics. Portsmouth: University of Portsmouth, School of Pharmacy and Biomedical Sciences, 1998.

Partridge, Malcolm Bruce Richard. A study of the In Vitro cytotoxicity of alkylaminoanthraquinone antitumour agents based on doxorubicin and mitozantrone. Leicester: Leicester Polytechnic, 1987.

Campbell, Colm J. Synthesis and study of platinum(II) and platinum(IV) complexes of EDTA derivatives as potential antitumour agents. Dublin: University College Dublin, 1996.

Tang, Kwan-Yuk. An investigation of the effects of antitumour and other drugs on cell morphology and the cytoskeleton of erythrocytes. Birmingham: Aston University. Department of Pharmaceutical Sciences, 1988.

Raleigh, Stuart Martin. Involvement of cytochromes P450 (CYP) and other haem associated enzymes in the bioreduction of AQ4N, and antitumour prodrug. Leicester: De Montfort University, 1998.

Basra, Jaspal. A study of free radical formation in liver and heart tissue by alkylaminoanthraquinone antitumour agents based on mitozantrone and doxorubicin. Leicester: School of Pharmacy, Leicester Polytechnic, 1986.

Gandecha, Bijukumar Mohanlal. Development of potential antitumour agents based on a consideration of the mode of action and pharmacokinetics of daunomycin and adriamycin. Leicester: Leicester Polytechnic, 1985.

Wilson, Stuart Craig. Design, synthesis and biological evaluation of a DNA cross-linking antitumour agent based onthe pyrrolo[2,1-c][1,4]benzodiazepine ring system. Portsmouth: University of Portsmouth, Division of Medicinal Chemistry and Natural Products, 1996.

Antitumor steroids. San Diego: Academic Press, 1992.

Lee, Moses, ed. Heterocyclic Antitumor Antibiotics. Berlin, Heidelberg: Springer Berlin Heidelberg, 2006. http://dx.doi.org/10.1007/11413073.

Puvvada, Madhu. Investigation into the relationship between DNA-binding affinity, sequence-specificity and biological activity in the pyrrolo[2,1-c][1,4]benzodiazepine group of antitumour antibiotics. Portsmouth: University of Portsmouth, Division of Medicinal Chemistry, 1995.

Mills, Lester S. Synthetic approaches to the antitumour-antibiotic CC-1065: Application of a new phase transfer catalyst to oxidation : investigation of an unexpected reaction of methoxyacetyl chloride. Norwich: University of East Anglia, 1985.

T, Hill Bridget, and Bellamy Angela S, eds. Antitumor drug-radiation interactions. Boca Raton, Fla: CRC Press, 1990.

Working group on molecular mechanisms of carcinogenic and antitumor activity (Città del Vaticano 1986). Molecular mechanisms of antitumor activity. Città del Vaticano: Pontificia Academia Scientiarum, 1987.

Muggia, Franco M., and Marcel Rozencweig, eds. Clinical Evaluation of Antitumor Therapy. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2317-4.

1932-, Borders Donald B., and Doyle Terrence W. 1942-, eds. Enediyne antibiotics as antitumor agents. New York: M. Dekker, 1995.

Maran, Carmen. Discovery and development of anthracycline antitumor antibiotics. Timisoara: Universitatea din Timișoara, Departementul de Chimie, 1994.

Parshikov, Igor A. Features of Antitumor and Antimalarial Artemisinins Biotransformations. Dallas, USA: Primedia E-launch LLC, 2018.

1923-, Takeuchi Tomio, Nitta Kazuo, Tanaka Nobuo 1926-, Umezawa Hamao, and Nihon Gan Gakkai, eds. Antitumor natural products: Basic and clinical research. Tokyo: Japan Scientific Societies Press, 1989.

Chu, Chung K., and David C. Baker, eds. Nucleosides and Nucleotides as Antitumor and Antiviral Agents. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-2824-1.

K, Chu Chung, Baker David C. 1946-, and Symposium on Nucleosides as Antitumor and Antiviral Agents (1992 : San Francisco, Calif.), eds. Nucleosides and nucleotides as antitumor and antiviral agents. New York: Plenum Press, 1993.

Lasek, Witold, and Radoslaw Zagozdzon. Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-46906-5.

Fang, Evandro Fei, and Tzi Bun Ng, eds. Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6214-5.

Fund, Pacific West Cancer, and National Cancer Coalition, eds. Cecropins: A class of lytic peptides : promising antibacterial and antitumor activity. Seattle, Wash: Distributed by National Cancer Coalition, 1997.

McDonald, Claire. Cecropins: A class of lytic peptides : promising antibacterial and antitumor activity. Seattle, Wash: Distributed by National Cancer Coalition, 1997.

Gielen, Marcel. Tin-Based Antitumour Drugs. Springer, 2011.

Gielen, Marcel. Tin-Based Antitumour Drugs. Springer London, Limited, 2013.

Wilman, D. E. Chemistry of Antitumour Agents. Springer Netherlands, 2011.

Wilman, D. E. Chemistry of Antitumour Agents. Springer London, Limited, 2012.

Gielen, Marcel. Tin-Based Antitumour Drugs. Springer, 2011.

The Chemistry of Antitumour Agents. Springer, 2011.

V, Wilman Derry E., ed. The Chemistry of antitumour agents. Glasgow: Blackie, 1990.